Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two Department of Physiology, Anatomy and Genetics (DPAG) projects aimed at tackling heart failure are to be funded by the 2022 TCS London Marathon with the British Heart Foundation (BHF) as its Charity of the Year, as two of eight handpicked BHF projects.

Branching blood vessels in the heart © Joaquim Vieira

Nearly a million people in the UK are living with heart failure, often a long-term consequence of damage caused by a heart attack. After a heart attack, the heart often fails to form adequate new blood vessels to fully heal.

Associate Professor Sarah De Val and Dr Alice Neal have been studying the pathways regulating the formation and differentiation of vein and lymphatic vessel in both development, and after a heart attack or other tissue damage. Not only are venous and lymphatic endothelial cells crucial for the correct function of the circulatory system, they can also be used as building blocks for other types of vessels.

Dr Joaquim Vieira is studying cells of the epicardium, the outer layer of the heart, which are vital to normal heart development, including the growth and maturation of coronary blood vessels, the myocardial (heart muscle) layer and cardiac valves. If we can understand how epicardial cells contribute to these processes, we can better understand what goes wrong, not only in adult heart disease, but also in congenital heart disease in children.

Read the full story on the DPAG website

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.